Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
|
|
Wall Street Journal - May 31, 2006
The British company also is adding two antiretroviral medicines to the scheme and has signed an eighth voluntary license agreement, allowing Sonke Pharmaceuticals of South Africa, a joint venture between South Africa's Community Investment Holdings and India's Ranbaxy Laboratories Ltd., to make generic copies of some of its drugs.
The moves are the latest in a series of price reductions by Glaxo and other AIDS-drug manufacturers, which have been criticized for not doing more to ensure access to life-saving treatments.
Glaxo has pledged to bring down prices as it achieves greater economies of scale. About 1.3 million people in the developing world currently take antiretrovirals, but most of the estimated 40 million infected people around the world are still unaware of their status.
060531
WJ060510
Copyright © 2006 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .